{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:55:42Z","timestamp":1780095342940,"version":"3.54.0"},"reference-count":37,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Obstruction of the biliary duct may be caused by various conditions ranging from chronic inflammation to neoplasia, including cholangiocarcinoma (CCA). While the definite histological diagnosis of intrahepatic lesions is relatively straightforward, the diagnostic workup of biliary duct stenosis can be challenging, despite the availability of novel tools for intraductal diagnosis. This proof-of-principle study aimed to investigate whether microRNAs (miRNAs) from bile duct stents may be used as biomarkers to differentiate between various bile duct diseases. Methods: For this purpose, we included 100 patients with one or more bile duct stents for various reasons, including malignant disease (n = 40), stenosis due to liver transplantation or surgery (n = 60), and cholangitis (n = 42). During endoscopic retrograde cholangiography, the stents were collected, and miRNA analyses were performed to evaluate miR-16, miR-21, and miR-223. Results: All studied miRNAs were successfully detected from the specimens obtained from the bile duct stents and were comparable in different stents from the same subjects. Following normalization, significant increases in miR-16, -21, and -223 levels were identified in patients with cholangitis compared to specimens from a non-inflammatory cohort. However, when comparing the data from patients in the malignant and non-malignant cohorts, the individual levels of miR-16, miR-21, and miR-223 showed high variation, without reaching a statistically significant difference. Conclusions: In summary, bile duct stents can be considered as potential sources of intraductal biomarkers, specifically miRNAs. Further profiling and validation analyses are necessary to identify the most appropriate miRNA targets for differentiating bile duct diseases.<\/jats:p>","DOI":"10.3390\/cancers17071171","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T02:50:16Z","timestamp":1743389416000},"page":"1171","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring microRNAs in Bile Duct Stents as Diagnostic Biomarkers for Biliary Pathologies"],"prefix":"10.3390","volume":"17","author":[{"given":"Noam Mathias","family":"Hipler","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosima","family":"Thon","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3213-8138","authenticated-orcid":false,"given":"Konrad","family":"Lehr","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6424-079X","authenticated-orcid":false,"given":"Manuele","family":"Furnari","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, Department of Internal Medicine, Policlinico San Martino-IRCCS Hospital, University of Genoa, 16145 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4090-586X","authenticated-orcid":false,"given":"Wilfried","family":"Obst","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Keitel","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Weigt","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-4562","authenticated-orcid":false,"given":"Alexander","family":"Link","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.gtc.2021.02.005","article-title":"Acute Cholangitis: Causes, Diagnosis, and Management","volume":"50","author":"An","year":"2021","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.14701\/ahbps.22-090","article-title":"Survival Analysis of Extrahepatic Cholangiocarcinoma Based on Surveillance, Epidemiology, and End Results Database","volume":"27","author":"Ali","year":"2023","journal-title":"Ann. Hepatobiliary Pancreat. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological Subclassification of Intrahepatic Cholangiocarcinoma: Etiological, Clinicopathological, and Molecular Features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: The next Horizon in Mechanisms and Management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.12659\/MSM.895040","article-title":"Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis","volume":"21","author":"Liang","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1111\/jog.14427","article-title":"Serum CA19-9, CA-125 and CEA as Tumor Markers for Mucinous Ovarian Tumors","volume":"46","author":"Lertkhachonsuk","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/bjc.1996.63","article-title":"Comparative Study of CA242 and CA19-9 in Chronic Pancreatitis","volume":"73","author":"Furuya","year":"1996","journal-title":"Br. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: Small RNAs with a Big Role in Gene Regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in Cancer: Biomarkers, Functions and Therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Condrat, C.E., Thompson, D.C., Barbu, M.G., Bugnar, O.L., Boboc, A., Cretoiu, D., Suciu, N., Cretoiu, S.M., and Voinea, S.C. (2020). MiRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis. Cells, 9.","DOI":"10.3390\/cells9020276"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. Elegans Heterochronic Gene Lin-4 Encodes Small RNAs with Antisense Complementarity to Lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Link, J., Thon, C., Petkevicius, V., Steponaitiene, R., Malfertheiner, P., Kupcinskas, J., and Link, A. (2023). The Translational Impact of Plant-Derived Xeno-MiRNA MiR-168 in Gastrointestinal Cancers and Preneoplastic Conditions. Diagnostics, 13.","DOI":"10.3390\/diagnostics13162701"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e1800076","DOI":"10.1002\/mnfr.201800076","article-title":"Food-Derived Xeno-MicroRNAs: Influence of Diet and Detectability in Gastrointestinal Tract-Proof-of-Principle Study","volume":"63","author":"Link","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1038\/ajg.2014.331","article-title":"A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select MiRNA in Plasma and Bile","volume":"109","author":"Cote","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/hep.22838","article-title":"MicroRNA-21 Is Overexpressed in Human Cholangiocarcinoma and Regulates Programmed Cell Death 4 and Tissue Inhibitor of Metalloproteinase 3","volume":"49","author":"Selaru","year":"2009","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.7150\/ijbs.59876","article-title":"MiR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation","volume":"17","author":"Jiao","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/joim.12099","article-title":"MiR-223: Infection, Inflammation and Cancer","volume":"274","author":"Haneklaus","year":"2013","journal-title":"J. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/ibd\/izy046","article-title":"Circulating and Fecal MicroRNAs as Biomarkers for Inflammatory Bowel Diseases","volume":"24","author":"Le","year":"2018","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.27050","article-title":"Human Bile Contains MicroRNA-Laden Extracellular Vesicles That Can Be Used for Cholangiocarcinoma Diagnosis","volume":"60","author":"Li","year":"2014","journal-title":"Hepatology"},{"key":"ref_21","first-page":"54036","article-title":"Isolation and Profiling of MicroRNA-Containing Exosomes from Human Bile","volume":"13","author":"Li","year":"2016","journal-title":"J. Vis. Exp."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s12072-021-10196-5","article-title":"Bile Extracellular Vesicles from End-Stage Liver Disease Patients Show Altered MicroRNA Content","volume":"15","author":"Nakashiki","year":"2021","journal-title":"Hepatol. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jhbp.512","article-title":"Tokyo Guidelines 2018: Diagnostic Criteria and Severity Grading of Acute Cholangitis (with Videos)","volume":"25","author":"Kiriyama","year":"2018","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lederer, T., Hipler, N.M., Thon, C., Kupcinskas, J., and Link, A. (2024). Comparison of Fecal MicroRNA Isolation Using Various Total RNA Isolation Kits. Genes, 15.","DOI":"10.3390\/genes15040498"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cncy.21966","article-title":"Expression of MicroRNAs in the Ascites of Patients with Peritoneal Carcinomatosis and Peritonitis","volume":"126","author":"Schindler","year":"2018","journal-title":"Cancer Cytopathol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Link, A., Becker, V., Goel, A., Wex, T., and Malfertheiner, P. (2012). Feasibility of Fecal MicroRNAs as Novel Biomarkers for Pancreatic Cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042933"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lange, T., Stracke, S., Rettig, R., Lendeckel, U., Kuhn, J., Schl\u00fcter, R., Rippe, V., Endlich, K., and Endlich, N. (2017). Identification of MiR-16 as an Endogenous Reference Gene for the Normalization of Urinary Exosomal MiRNA Expression Data from CKD Patients. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183435"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1158\/1055-9965.EPI-10-0027","article-title":"Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening","volume":"19","author":"Link","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/0973-1482.193125","article-title":"Circulating MicroRNA-21 as a Prognostic, Biological Marker in Cholangiocarcinoma","volume":"14","author":"Liu","year":"2018","journal-title":"J. Cancer Res. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.3748\/wjg.v24.i30.3313","article-title":"MicroRNAs as Non-Invasive Diagnostic Biomarkers for Gastric Cancer: Current Insights and Future Perspectives","volume":"24","author":"Link","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.dld.2020.11.010","article-title":"The Diagnostic Value of Exosomal MiRNAs in Human Bile of Malignant Biliary Obstructions","volume":"53","author":"Ge","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Shigehara, K., Yokomuro, S., Ishibashi, O., Mizuguchi, Y., Arima, Y., Kawahigashi, Y., Kanda, T., Akagi, I., Tajiri, T., and Yoshida, H. (2011). Real-Time PCR-Based Analysis of the Human Bile MicroRNAome Identifies MiR-9 as a Potential Diagnostic Biomarker for Biliary Tract Cancer. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023584"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3748\/wjg.v24.i1.112","article-title":"Characterization of Biofilms in Biliary Stents and Potential Factors Involved in Occlusion","volume":"24","author":"Vaishnavi","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/ajcp\/aqac015","article-title":"Analysis of MicroRNA in Bile Cytologic Samples Is Useful for Detection and Diagnosis of Extrahepatic Cholangiocarcinoma","volume":"158","author":"Uchihata","year":"2022","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15403\/jgld-4710","article-title":"Factors Affecting Performance of DNA Methylation as a Potential Biomarker in Ascites for Peritonitis and Peritoneal Carcinomatosis","volume":"32","author":"Bose","year":"2023","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Han, J.-Y., Ahn, K.S., Kim, T.-S., Kim, Y.H., Cho, K.B., Shin, D.W., Baek, W.-K., Suh, S.-I., Jang, B.-C., and Kang, K.J. (2021). Liquid Biopsy from Bile-Circulating Tumor DNA in Patients with Biliary Tract Cancer. Cancers, 13.","DOI":"10.3390\/cancers13184581"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Casadio, M., Biancaniello, F., Overi, D., Venere, R., Carpino, G., Gaudio, E., Alvaro, D., and Cardinale, V. (2021). Molecular Landscape and Therapeutic Strategies in Cholangiocarcinoma: An Integrated Translational Approach towards Precision Medicine. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115613"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/7\/1171\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:06:17Z","timestamp":1760029577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/7\/1171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["cancers17071171"],"URL":"https:\/\/doi.org\/10.3390\/cancers17071171","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]}}}